SecBot SecBot
Institutional Cluster

AXGN

Axogen, Inc.
MIXED
Impact 5/10
Horizonweeks Processed4mo ago
Institutional cluster: 21 buyers, 13 sellers (mixed)
Actionable Insight ◆ Mixed

The Q1 2026 13F cluster shows strong net buying ($67.6M) from active managers like Wellington, Balyasny, and Holocene, but the divergence with Arrowstreet, Connor Clark & Lunn, and Marshall Wace trimming large positions creates a mixed signal. The absence of insider buying (confluence score 23/100) weakens conviction. Monitor upcoming earnings for revenue growth trajectory and margin expansion to see which side of the trade is validated.

DirectionMixed
Confidencemedium
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$43.62
T+0 close · Jul 9, 2026 · via day close
Latest settled
−14.28%
T+60 · $37.39
Vs SPY
−15.92%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jul 9 $43.62entry
  2. T+1 · 4mo ago −6.97%α −7.40% · $40.58
  3. T+5 · 4mo ago −8.81%α −8.68% · $39.78
  4. T+20 · 3mo ago +1.67%α −0.57% · $44.35
  5. T+60 · 7w ago −14.28%α −15.92% · $37.39

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

A mixed institutional cluster in AXGN for Q1 2026 shows 21 buyers accumulating $103.2M in new positions (led by Fidelity, Wellington, and Holocene Advisors) while 13 sellers reduced holdings by $35.6M. The net buying of ~$67.6M is dominated by active asset managers, suggesting a shared thesis around Axogen's growth story, but the presence of significant trimming by Arrowstreet, Marshall Wace, and Connor Clark & Lunn introduces caution. The cluster is directionally bullish in aggregate but with notable divergence among sophisticated managers.

Key Financial Metrics

Direction
accumulating
Buy Value
$155.1M
Sell Value
$35.6M
Net Flow
$67.6M

Institutional Positions

Net institutional flow: $67.6M

▲ Buyers (21)

InstitutionActionChangePosition ValueValue Δ
FidelityDOUBLED+655.2%$43.5M$37.8M
Wellington Management GroupNEWNot reported$32.0M$32.0M
Holocene AdvisorsNEWNot reported$18.3M$18.3M
Balyasny Asset ManagementADD+28.3%$36.0M$8.3M
Wcm Investment ManagementADD+39.7%$17.5M$4.4M

▼ Sellers (13)

InstitutionActionChangePrev ValueValue Δ
Arrowstreet Capital, Limited PartnershipTRIM-63.5%$23.2M-$14.6M
Connor, Clark & Lunn Investment ManagementTRIM-62.7%$13.1M-$8.2M
Marshall WaceNEAR_EXIT-77.6%$4.9M-$3.8M
JPMorganTRIM-34.5%$9.4M-$3.5M
Arrowstreet Capital, Limited PartnershipTRIM-63.5%$23.2M-$14.6M

Key Facts

  • 21 institutional buyers added $103.2M in new positions during Q1 2026, while 13 sellers reduced holdings by $35.6M
  • Fidelity doubled its stake to 1.31M shares ($43.5M), the largest buyer by dollar value
  • Wellington Management Group initiated a new $32.0M position (964.6K shares)
  • Holocene Advisors initiated a new $18.3M position (553.8K shares)
  • Balyasny Asset Management added $8.3M to its existing position, now holding $36.0M
  • Arrowstreet Capital trimmed 63.5% of its position, selling $14.6M worth
  • Connor, Clark & Lunn trimmed 62.7%, selling $8.2M worth
  • Marshall Wace nearly exited, selling 77.6% of its position ($3.8M)
  • Net buying of ~$67.6M is dominated by active asset managers, not passive rebalancing
  • Insider activity is divergent (score 23/100), no open-market insider buying corroborates the institutional accumulation

Financial Impact

21 institutional buyers added $103.2M in new positions while 13 sellers reduced holdings by $35.6M, for net institutional accumulation of ~$67.6M during Q1 2026

institutional ownershipfloat

Risk Factors

  • 13F data is 45+ days stale, positions may have been unwound since quarter-end
  • Significant selling by Arrowstreet ($14.6M), Connor Clark & Lunn ($8.2M), and Marshall Wace ($3.8M) suggests some sophisticated managers are taking profits or reducing conviction
  • No insider open-market buying to corroborate the institutional accumulation

Market Snapshot

Exchange
Nasdaq
Sector
Electromedical & Electrotherapeutic Apparatus
Analyst Consensus
94% bullish (16 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-AXGN-2026-Q1

Track record

19 reports on AXGN

Performance horizon

4 of 6 bullish or bearish reports moved the stock their way by T+20. Best: +32.04% at T+20 after the Oct 1, 2026 report. 8 of 8 went positive at some point.

Filters
  1. Nov 13, 20263d ago SC 13G/A Bearish 5/10 Entry $55.78 settles Dec 15
  2. Nov 9, 20267d ago 8-K Bullish 5/10 Entry $50.64 settles Dec 8
  3. Nov 4, 202612d ago Institutional Cluster Neutral 3/10 Entry $51.35 settles Dec 3
  4. Oct 28, 202619d ago 8-K Bullish 6/10 No price data
  5. Oct 28, 202619d ago Press Release Bullish 6/10 Entry $49.25 settles Nov 25
  6. Oct 2, 20266w ago SC 13G Neutral 4/10 Entry $37.22 to $49.37 ▲ +32.64% +35.11% vs SPY
  7. Oct 1, 20266w ago 8-K Bullish 6/10 Entry $37.39 to $49.37 ▲ +32.04% +33.85% vs SPY
  8. Oct 1, 20266w ago Press Release Bullish 6/10 Entry $37.39 to $49.37 ▲ +32.04% +33.85% vs SPY
  9. Sep 10, 20269w ago 424B5 Mixed 6/10 Entry $42.16 to $36.13 ▼ −14.30% −16.17% vs SPY
  10. Sep 10, 20269w ago 8-K Bullish 7/10 Entry $41.85 to $36.18 ▼ −13.55% −15.67% vs SPY
Showing 10 of 19

US Market Status

Market Closed · Opens in 6h 7m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 9, 2026